Post-traumatic stress disorder
Drug research and approvals for post-traumatic stress disorder: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.
As of Nov 16, 2026, 400 studies of post-traumatic stress disorder are recruiting on ClinicalTrials.gov, and Health Canada has authorized 25 drug trials for it since 2013.
- Recruiting worldwide: 400
- Trials authorized in Canada: 25
- FDA orphan approvals: 0
- EU medicines: 0
Recruiting Now
Newest start dates first, of 400 recruiting on ClinicalTrials.gov ↗- Rehabilitation Through Virtual Immersion & Integrated Exposure for Mild Traumatic Brain Injury (ReVIVE for mTBI)NCT07890337 · Phase 1 · Johns Hopkins University · starts Nov 1, 2026
- Eye Movement Intervention With Different Memory Reactivation Procedures for Intrusive Traumatic MemoriesNCT07767396 · Not applicable · Shaanxi Normal University · starts Oct 30, 2026
- Morphine or Ketamine for AnalgesiaNCT06835504 · Phase 3 · Columbia University · starts Oct 17, 2026
- Virtual Reality Assisted Trauma Focused CBTNCT07914634 · Not applicable · Queen's University, Belfast · starts Oct 5, 2026
- Comparative Effectiveness of SPARCS and Unified Protocol for Youth With Chronic Medical Conditions and Trauma-Related…NCT07483333 · Not applicable · Anthony Vesco · starts Oct 1, 2026
- Hyperbaric Oxygen Therapy for Veterans With TBI and PCS: A Biomarker StudyNCT07849465 · Phase 2 · Summit Hyperbarics and Wellness · starts Oct 1, 2026
- An Evaluation of the Safety and Efficacy of TSND-201 for the Treatment of PTSDNCT07836647 · Phase 3 · Transcend Therapeutics · starts Sep 25, 2026
- Psychological Prehabilitation for Complex Gastrointestinal SurgeryNCT07865052 · Not applicable · Northwestern University · starts Sep 25, 2026
- Deep Brain Reorienting for Posttraumatic Stress DisorderNCT07840417 · Not applicable · University of Alberta · starts Sep 21, 2026
- Redefine Study: A Study Evaluating the Efficacy, Safety, and Tolerability of COMP360 in Participants With…NCT07570654 · Phase 2 / Phase 3 · COMPASS Pathways · starts Sep 14, 2026
Trials Authorized in Canada
The 10 newest of 25; search them all in Canada trials| Jun 17, 2026 | A phase 2b/3, multicentre, randomised, double-blind, controlled trial, with an open label extension, to investigate the efficacy, safety, and tolerability of…COMP360 (PSILOCYBIN) | COMPASS PATHFINDER LIMITED | Ongoing |
| Jun 8, 2026 | Psilocybin-assisted therapy for post-traumatic stress disorder in survivors of intimate partner violence.PSILOCYBIN (PEX010) | GOVERNORS OF THE UNIVERSITY OF CALGARY | Ongoing |
| Jul 14, 2025 | Ketamine assisted psychotherapy to improve quality of life in veterans and civilians with comorbid chronic pain and posttraumatic stress disorder: an…KETAMINE | DR. YULIYA KNYAHNYTSKA | Ongoing |
| Feb 5, 2024 | A multi-site phase 3 study of the efficacy of mdma-assisted psychotherapy for the treatment post-traumatic stress disorder in veterans and front-line workersMETHYLENEDIOXYMETHAMPHETAMINE (MDMA) | ATMA JOURNEY CENTRES | Pending |
| Jul 26, 2023 | Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: an open-label trialPSILOCYBIN | ST. MICHAEL'S HOSPITAL UNITY HEALTH TORONTO | Ongoing |
| Apr 14, 2023 | A randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability and efficacy of psilocybin-assisted psychotherapy in treating severe…PSILOCYBIN (APEX-002-A02) | APEX LABS LTD | Pending |
| Mar 10, 2023 | Stellate ganglion block in the treatment of posttraumatic stress disorder: outcome evaluation, mechanism of action, and integration in care ¿ a phase III…BUPIVACAINE | UNIVERSITY OF OTTAWA INSTITUTE OF MENTAL HEALTH RESEARCH | Ongoing |
| Jan 4, 2023 | A randomized, double-blind, placebo-controlled study to evaluate the efficacy, safety and tolerability of psilocybin capsule in treating moderate depression…PSILOCYBIN (APEX-002-B01) | APEX LABS INC. | Pending |
| Aug 3, 2022 | Psilocybin assisted therapy for anxiety and mood disorders: a transdiagnostic open label clinical trial for improving well-being (pam-well)PSILOCYBIN | BRAIN AND COGNITION DISCOVERY FOUNDATION | Closed |
| Jul 7, 2022 | Standard vs. modified reconsolidation interventions for public safety personnel diagnosed with post-traumatic stress disorder: a proposed pilot studyPROPRANOLOL | DOUGLAS MENTAL HEALTH UNIVERSITY INSTITUTE | Pending |
Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA